Biomonitoring Study

 • Title 

 • Abstract 

 • Introduction 

 • Methods 

 • Results 

 • Discussion 

 • Conclusions 

 • References 

 • Tables 

Biomonitoring Data for 2,4-Dichlorophenoxyacetic Acid in the US and Canada: Interpretation in a Public Health Risk Assessment Context Using Biomonitoring Equivalents

Lesa L. Aylward¹, Marsha K. Morgan², Tye E. Arbuckle³, Dana B. Barr⁴, Carol J. Burns⁵,
Bruce H. Alexander⁶, Sean M. Hays⁷

Summit Toxicology, LLP, Falls Church, VA 22044  

United States Environmental Protection Agency, Research Triangle Park, North Carolina, 27711

Environmental Health Science and Research Bureau, Health Canada, Ottawa ON K1A 0K9

National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA 30341

The Dow Chemical Company, Midland, MI 48674

Division of Environmental Health Sciences, School of Public Health, University of Minnesota, Minneapolis, MN 55455

Summit Toxicology, LLP, Lyons, CO 80540

* Corresponding author:
Lesa L. Aylward
Summit Toxicology, LLP
6343 Carolyn Drive
Falls Church, VA 22044
Phone: (703) 349-3515
Fax: (303) 747-0286
laylward@summittoxicology.com

Next: Abstract